Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD52 antibody

The Rat Monoclonal anti-CD52 antibody has been validated for FACS and IP. It is suitable to detect CD52 in samples from Mouse.
Catalog No. ABIN1449230

Quick Overview for CD52 antibody (ABIN1449230)

Target

See all CD52 Antibodies
CD52

Reactivity

  • 57
  • 21
  • 7
  • 5
  • 5
  • 2
  • 1
Mouse

Host

  • 23
  • 19
  • 19
  • 2
Rat

Clonality

  • 51
  • 6
  • 3
Monoclonal

Conjugate

  • 36
  • 9
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD52 antibody is un-conjugated

Application

  • 41
  • 25
  • 25
  • 18
  • 15
  • 14
  • 14
  • 10
  • 10
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP)

Clone

BTG-2G
  • Specificity

    This antibody reacts with mouse CAMPATH-1/CD52.

    Purification

    Protein G agarose

    Immunogen

    Mouse IL-2R alpha-TGM splenocyte

    Isotype

    IgG2a
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS containing 50 % glycerol, pH 7.2. Contains no preservatives.

    Preservative

    Without preservative

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Upon receipt, store (in aliqouts) at -20 °C.
  • Target

    CD52

    Alternative Name

    CD52 / CAMPATH-1

    Background

    CAMPATH-1, also known as CD52, is a heavily glycosylated, GPI-anchored protein expressed at high levels on almost all thymocytes, lymphocytes, monocytes, and macrophages. The function of CD52 is unknown. However, CD52 is an exceptionally good target for complement-mediated cell lysis and antibody-mediated cellular cytotoxicity. Humanized CAMPATH-1antibodies have been used therapeutically to effectively deplete lymphocytes in allogeneic bone marrow transplants, hematologic malignancies, and autoimmune diseases. Clinical trials suggest CAMPATH-1 antibodies are especially promising in the treatment of leukemia, non-Hodgkin lymphomas, and rheumatoid arthritis. The apparent size of CAMPATH-1 by SDS-PAGE is 25-29 kDa, however, the actual molecule is much smaller, ~ 8-9 kDa as confirmed by total structure analysis and mass spectrometry.Synonyms: CDw52, Cambridge pathology 1 antigen, Epididymal secretory protein E5, HE5

    Gene ID

    23833

    NCBI Accession

    NP_038734

    UniProt

    Q64389
You are here:
Chat with us!